Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Aclaris Therapeutics Inc.

    NASDAQ: ACRS · Real-Time Price · USD
    1.86
    0.17 (10.06%)
    At close: Aug 15, 2025, 3:08 PM

    Aclaris Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 18.72M 31.25M 29.75M 6.76M
    Cost of Revenue
    		 2.79M 18.08M 11.96M 4.71M
    Gross Profit
    		 15.93M 13.17M 17.79M 2.05M
    Operating Income
    		 -141.93M -97.36M -89.85M -65.38M
    Interest Income
    		 7.95M n/a n/a n/a
    Pretax Income
    		 -132.06M -88.85M -86.91M -90.86M
    Net Income
    		 -132.06M -88.48M -86.91M -90.86M
    Selling & General & Admin
    		 22.2M 31.1M 25.13M 23.62M
    Research & Development
    		 33.59M 98.38M 77.81M 43.81M
    Other Expenses
    		 102.07M -18.96M n/a 24.34M
    Operating Expenses
    		 157.86M 110.53M 102.95M 91.77M
    Interest Expense
    		 n/a n/a 4.7M n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 160.65M 128.61M 119.61M 96.48M
    Income Tax Expense
    		 n/a -367K 1.75M 23.42M
    Shares Outstanding (Basic)
    		 77.3M 69.81M 65.21M 56.73M
    Shares Outstanding (Diluted)
    		 77.3M 69.81M 65.21M 56.73M
    EPS (Basic)
    		 -1.71 -1.27 -1.33 -1.6
    EPS (Diluted)
    		 -1.71 -1.27 -1.33 -1.6
    EBITDA
    		 -51.72M -87.98M -84.36M -64.46M
    EBIT
    		 -52.53M -114.51M -85.15M -65.38M
    Depreciation & Amortization
    		 807K 863K 797K 923K

    Add to Watchlist